The current study also compared the roles of HDL and apoA1 in all three aforementioned COVID-19-related outcomes, i.e., SARS-CoV-2 infection, severe cases of COVID-19, which was defined by the need for hospitalization, and the development of AKI as a result of COVID-19, in a single study. The gene discussed is APOA1; the disease is COVID-19.